These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34800314)

  • 1. Current status and role of antiphospholipid antibody testing in cryptogenic stroke.
    Yang W; Kang MK; Ha SY; Kang DW; Bae J; Lee EJ; Jeong HY; Kim JM; Jung KH; Lee SH
    Eur J Neurol; 2022 Mar; 29(3):753-760. PubMed ID: 34800314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of patients with transient and sustained increments of antiphospholipid antibodies after acute ischemic stroke.
    Yoo JS; Kim YS; Kim HY; Kwon HS; Koh SH; Heo SH; Kim BJ; Bushnell CD; Chang DI
    J Neurol; 2021 Jul; 268(7):2541-2549. PubMed ID: 33547954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ischemic stroke with antiphospholipid antibody].
    Kitagawa Y; Ohkuma H; Tokuoka K
    Brain Nerve; 2008 Oct; 60(10):1144-58. PubMed ID: 18975602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study.
    Rajamani K; Chaturvedi S; Jin Z; Homma S; Brey RL; Tilley BC; Sacco RL; Thompson JL; Mohr JP; Levine SR;
    Stroke; 2009 Jul; 40(7):2337-42. PubMed ID: 19498198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity.
    Pyo JY; Jung SM; Lee SW; Song JJ; Lee SK; Park YB
    Yonsei Med J; 2017 Nov; 58(6):1128-1134. PubMed ID: 29047236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and potential treatment of antiphospholipid syndrome-related mainly on ischemic stroke].
    Okuma H; Kitagawa Y
    Brain Nerve; 2013 Nov; 65(11):1319-32. PubMed ID: 24200610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
    Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP;
    JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging features of antiphospholipid antibody-related stroke compared with atrial fibrillation-related stroke.
    Yang W; Kang DW; Kim JM; Jung KH; Lee SH
    Sci Rep; 2022 Jul; 12(1):11686. PubMed ID: 35804027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
    Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
    J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile.
    Pengo V; Ruffatti A; Del Ross T; Tonello M; Cuffaro S; Hoxha A; Banzato A; Bison E; Denas G; Bracco A; Padayattil Jose S
    J Thromb Haemost; 2013 Aug; 11(8):1527-31. PubMed ID: 23601766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of stroke patients with antiphospholipid antibodies.
    Terashi H; Uchiyama S; Hashimoto S; Miyazaki K; Tsutsumi Y; Yamazaki M; Iwata M
    Cerebrovasc Dis; 2005; 19(6):384-90. PubMed ID: 15863981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
    Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?
    Berkun Y; Simchen MJ; Strauss T; Menashcu S; Padeh S; Kenet G
    Lupus; 2014 Sep; 23(10):986-93. PubMed ID: 24729280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes.
    Wolgast LR; Arslan AA; Wu XX; Beyda JN; Pengo V; Rand JH
    J Thromb Haemost; 2017 Jul; 15(7):1412-1421. PubMed ID: 28393472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies during infectious mononucleosis and their long term clinical significance.
    Ben-Chetrit E; Wiener-Well Y; Fadeela A; Wolf DG
    J Clin Virol; 2013 Apr; 56(4):312-5. PubMed ID: 23290387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Confirmation of antiphospholipid antibody positivity: a year's results in a cohort of 113 patients].
    Cuffaro S; Del Ross T; Tonello M; Bontadi A; Olivieri S; Salvan E; Ruffatti A; Punzi L
    Reumatismo; 2010; 62(1):51-9. PubMed ID: 20390118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
    Amory CF; Levine SR; Brey RL; Gebregziabher M; Tuhrim S; Tilley BC; Simpson AC; Sacco RL; Mohr JP;
    Cerebrovasc Dis; 2015; 40(5-6):293-300. PubMed ID: 26513489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.